MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-28-0008235
PFC Pharma Focus India Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹60.98 Lakh
▼ 42% YoY
Net loss · FY 2024
₹45.8 Lakh
Net margin -75.1%
EBITDA · FY 2024
-₹41.51 Lakh
EBITDA margin -68.1%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹24.32 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About PFC Pharma Focus India Private Limited
Data last updated:
PFC Pharma Focus India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Excel Life Sciences Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 June 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC179947. Its GSTIN is 09AAECP7750R1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹24.32 Lakh. It is led by directors including Kavitha Jeya Pushparani Joseph and Joseph Innocent Babola Stanislaus Amalraj.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot – 121 Basement Pocket – 1 Jasola, New Delhi, Delhi, India – 110025.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.98 Lakh, a decline of 42% compared to the previous year. For the same year it recorded a net loss of ₹45.8 Lakh (net margin -75.1%) and EBITDA of -₹41.51 Lakh (EBITDA margin -68.1%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years and 14% over five years.
The company is associated with 1 brand: PFC Pharma Focus India.
PFC Pharma Focus India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0008235). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pfcpharma.com.
Company details
CIN U24232DL2008PTC179947
Registration Number 179947
Incorporation Date 23 June 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Excel Life Sciences Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0008235
Key People
Kavitha Jeya Pushparani Joseph Director Joseph Innocent Babola Stanislaus Amalraj Director Saurendra Das Additional Director Recognitions & Rankings of PFC Pharma Focus India
Contact details
PFC Pharma Focus India Private Limited's registered office is in New Delhi, Delhi. Its website is pfcpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot – 121 Basement Pocket – 1 Jasola, New Delhi, Delhi, India – 110025
- IndustryPharma, Pharma Contract R&D
To see the full contact details of PFC Pharma Focus India Private Limited, buy the company report.
Comprehensive company report
PFC Pharma Focus India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
PFC Pharma Focus India operates one associated brand: PFC Pharma Focus India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical trial management services in pharmaceuticals and biotechnology. | pfcpharma.com |
Business activity
The main business activity of PFC Pharma Focus India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of PFC Pharma Focus India Private Limited, buy the company report.
Financials of PFC Pharma Focus India Private Limited
FY 2025 filings availablePFC Pharma Focus India Private Limited reported revenue of ₹60.98 Lakh (down 42% YoY) for FY 2024.
Revenue · FY 2024
₹60.98 Lakh ▼ 42%
Net loss · FY 2024
₹45.8 Lakh margin -75.1%
EBITDA · FY 2024
-₹41.51 Lakh margin -68.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 42%
3 years · compounded
▼ 38%
5 years · compounded
▼ 14%
EBITDA CAGR growth
3 years · compounded
▼ 32%
5 years · compounded
▼ 24%
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 42% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹41.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹45.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -68.1% | ||||
| Net Profit Margin | -75.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of PFC Pharma Focus India Private Limited, buy the company report.
Board of directors of PFC Pharma Focus India Private Limited
PFC Pharma Focus India has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavitha Jeya Pushparani Joseph | Director | 12 Feb 2021 | 5 Years 8 Months | Current |
| Joseph Innocent Babola Stanislaus Amalraj | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
| Saurendra Das | Additional Director | 15 Oct 2024 | 2 Years 0 Months | Current |
Auditor
PFC Pharma Focus India Private Limited is audited by K.K.MANKESHWAR & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.K.MANKESHWAR & CO. | FY 2022 | 106009W |
Shareholding
The shareholding of PFC Pharma Focus India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of PFC Pharma Focus India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving PFC Pharma Focus India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
PFC Pharma Focus India Private Limited has 3 MSME Form 1 returns on record between 2020 and 2021, listing 93 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| HNND Trading Private Limited | |||
| Pioneer Eserve Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Chatterjee Cleaning Arts Services Limited |
To see the full MSME payment records of PFC Pharma Focus India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
PFC Pharma Focus India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECP7750R1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of PFC Pharma Focus India Private Limited, buy the company report.
Recent activity
PFC Pharma Focus India Private Limited has 12 board changes on record since 2010: 3 appointments and 9 cessations. The latest: Raman Sehgal ceased to be Director on 06 Dec 2024.
AGM
Pfc Pharma Focus India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pfc Pharma Focus India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Raman Sehgal ceased to be Director.
Appointed
Saurendra Das was appointed as Additional Director.
Ceased
Joseph Innocent Babola Stanislaus Amalraj ceased to be Additional Director.
Ceased
Kavitha Jeya Pushparani Joseph ceased to be Director.
Appointed
Joseph Innocent Babola Stanislaus Amalraj was appointed as Director.
Appointed
Kavitha Jeya Pushparani Joseph was appointed as Director.
Ceased
Natasha Das ceased to be Director.
Ceased
Raminder Singh Taneja ceased to be Director.
Ceased
Trilok Nath Mehrotra ceased to be Managing Director.
Ceased
Kathryn Joanne Vogeli Kull ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
PFC Pharma Focus India is an active private limited company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 June 2008 (18+ years old) and is registered under CIN U24232DL2008PTC179947.
PFC Pharma Focus India has 3 current directors:
- Kavitha Jeya Pushparani Joseph - Director
- Joseph Innocent Babola Stanislaus Amalraj - Director
- Saurendra Das - Additional Director
The latest financial statements of PFC Pharma Focus India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of PFC Pharma Focus India is 09AAECP7750R1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of PFC Pharma Focus India is U24232DL2008PTC179947. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PFC Pharma Focus India was incorporated on 23 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Raman Sehgal ceased to be Director on 06 Dec 2024. Saurendra Das was appointed as Additional Director on 15 Oct 2024. Joseph Innocent Babola Stanislaus Amalraj ceased to be Additional Director on 30 Sep 2022. PFC Pharma Focus India has 12 board changes on record in total.
Yes, PFC Pharma Focus India is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0008235).
PFC Pharma Focus India has 3 MSME Form 1 returns on record between 2020 and 2021, listing 93 overdue payments to 9 micro and small suppliers. The latest return was filed on 28 Oct 2021.
PFC Pharma Focus India can be reached through the website pfcpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of PFC Pharma Focus India is at Plot – 121 Basement Pocket – 1 Jasola, New Delhi, Delhi, India – 110025.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages